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ABSTRACT 
Rebecca Fletcher 
 
 
FACILITATING PHARMACOGENETIC ASSOCIATION STUDIES USING AN 
EXTENSIBLE GENOTYPE INFORMATION MANAGEMENT SYSTEM 
 
Large-scale genome data projects employing automated, high-throughput techniques 
have led to a deluge of genomic data that necessitate robust informatic solutions.  COBRA-
DB is an integrated web-based genome information management system that provides 
storage for pharmacogenomic information including genotypic, phenotypic and resequencing 
data.  The system provides an integrated solution for the acquisition, organization, storage, 
retrieval and analysis of pharmacogenomic data and offers a platform for genome 
annotation and analysis.  The system also includes an export utility to automate 
submission of data to other bioinformatic resources and public data repositories.  A web 
interface provides flexible data import and export options and allows users to access and 
download data via simple query forms.  The COBRA database is dedicated to the efficient 
management of pharmacogenomic data with the intent to facilitate genotype-phenotype 
association studies and catalyze pharmacogenomic research.  COBRA-DB is an internal, 
proprietary application in use by the Division of Clinical Pharmacology at Indiana University 
School of Medicine. 
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Chapter One: Introduction 
In the post-genomic era, large-scale scientific projects have led to a new scientific 
emphasis on genetic variation and related phenotypes.  Focusing on the associations 
between sequence variation and resulting traits has in turn driven the next generation of 
database technologies (Frenkel 1991).  In 1990 the U.S. Department of Energy and the 
National Institutes of Health formally launched the Human Genome Project (HGP) to 
identify all the genes in the human genome and to determine the specific sequence of 
nucleotides that comprise human DNA.  This thirteen year long project represented an 
unprecedented scientific undertaking which helped spawn a new era of innovation not 
only in medicine but also in technology.  Processing data in the post-genomic era 
presents new challenges which necessitate the engineering of novel information systems.  
Unlike traditional commercial or engineering datasets that were smaller, more static and 
less complex, genetic data are large-scale, more fluid in nature and multifaceted.  As a 
result, investigators require robust information systems that can handle the inherent 
complexities of genomic data.   
Genotype/Phenotype Databases 
High-throughput genotyping and DNA sequencing technologies present researchers 
with unprecedented opportunities for performing genome analysis.  However, these technical 
advances have made it increasingly more difficult to manage the resulting deluge of 
information.  Public repositories for phenotype, genotype and sequence data are being 
developed in an effort to help manage the burgeoning data.  These so-called 
genotype/phenotype databases store data at the level of individuals and are functional 
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resources for investigators who are interested in studying genetic variation and associations 
with observable traits. 
In general, phenotype is determined not only by genotype but by environmental 
influences, as well.  For example, genotypes will not result in equal phenotypes in all 
environments.  Instead, a genotype may produce a favorable phenotype under a certain set of 
conditions yet produce a negative outcome under a different set of variables.  This is known 
as phenotypic plasticity (Price et al, 2003).  Therefore, the interaction between genetics and 
environmental factors is highly significant.  Unfortunately, however, accounting for 
environmental factors is complicated.  Often times, environmental factors are difficult to 
measure and even when they are easily registered, recording them is another obstacle.  
Although it is more appropriate to describe phenotype as a function of genotype and the 
environment, with the exception of a small number of self-reported facts (i.e., concomitant 
medications), limited environmental information is available.  As a result, for the purpose of 
this project, environmental factors will be included where available but do not represent a 
major contribution to the results. 
Pharmacogenomic Association Studies 
Pharmacogenomics is the intersection of pharmacology and genomics and studies 
how an individual’s genetic variation affects drug response.  The discipline combines 
pharmacy, biochemistry and molecular biology with annotation about the human genome 
and genetic variation to improve our understanding of how genetic inheritance affects 
disease. 
Genetic association studies explore the connection between genetic composition 
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or genotype and the outward manifestation of that genetic composition or phenotype.   
Genome-wide association studies (GWAS) examine genetic variation across the entire 
human genome.  In Pharmacogenomics, GWA studies have made it possible to identify 
genetic factors that are associated with drug response.   
COBRA and Breast Cancer Pharmacogenomics 
This project focuses on the development of an information management system to 
support the Consortium on Breast Cancer Pharmacogenomics (COBRA).  COBRA is a 
member of the Pharmacogenomics Research Network (PGRN), a collaborative group of 
investigators who focus on correlating drug response phenotypes with genetic variation.  
COBRA’s mission is to study how multiple genetic variations affect clinical 
pharmacology in order to accelerate breast cancer research.  
More specifically, COBRA is interested in understanding how genetic 
polymorphisms affect normal estrogen function and how these variations impact breast 
cancer treatments (Ntukidem et al, 2008).  COBRA aims to identify genetic variants in 
the estrogen receptors (ER-α and ER-β) and drug metabolizing enzymes that are involved 
in aromatase inhibitor hormone therapy.  COBRA also studies genetic variants and their 
associations with specific phenotypes such as hot flashes or bone density in breast cancer 
patients (Table 1). 
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 Table 1 List of phenotypes studied by COBRA 
 
 
• Breast 
– Mammography 
• Bone  
– Densitometry 
– Bone turnover markers 
• Quality of Life 
– Questionnaire name 
– Rheumatologic symptoms 
• Endocrine 
– Estrogens 
– Androgens 
– Thyroid markers 
• Hot Flash 
– Objective monitoring 
– Diaries 
• Pharmacokinetics 
– Tamoxifen 
– Letrozole  
– Exemestane  
– Anastrozole 
• Cardiovascular 
– Lipids 
– Platelets 
– Inflammatory markers 
 
 
COBRA uses a combined bioinformatic and direct sequencing approach to test for 
variants in candidate genes.  Once results from high throughput techniques are generated, 
researchers need a straightforward method to easily access the results.    
Gap in Data Management 
Managing data is a major challenge.  In order to be useful, data must be prepared 
so that it is convenient and easy to access.  When we lack the proper tools to efficiently 
cope with data, there is a severe risk that data will be ignored or lost.  In a worst case 
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scenario, a researcher might actually find it easier to reproduce results as opposed to 
simply querying a database to retrieve his data.  We proposed the following integrated 
informatics solution in an effort to eliminate the risk to data integrity.  Proper data 
management represents a critical component of successful research and the lack thereof is 
often a rate limiting step in research.   Data should be centralized, secure, accessible, 
standardized, distributable and redundant. 
Description and Scope of Project 
The COBRA-DB warehouses data generated as part of the Tamoxifen 
Pharmacogenetics and Clinical Effects
1
 trial sponsored by the National Institute of 
General Medical Sciences (NIGMS).  The goal of the trial is to determine how breast 
cancer patients respond to the cancer drug tamoxifen that affects the activity of the 
female hormone estrogen (Goetz et al, 2005).  The study will test the following 
hypotheses. 
1. “There is a relationship between genetically distinct metabolic profiles of 
tamoxifen and the frequency and severity of hot flashes in women on chronic 
tamoxifen therapy. 
2. Genetically distinct metabolic profiles for tamoxifen effect lipid profile, bone 
turnover metabolites and bone mineral density, and coagulation factors. 
3. Different genetic profiles of estrogen responsive genes influence the 
pharmacodynamic effects of tamoxifen in cardiovascular system”. 
                                                 
1
 Official Title: A Pilot Trial Correlating Metabolic Profile of Tamoxifen With Pharmacogenetic Predictors 
and Clinical Effects 
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COBRA aims to sequence the estrogen receptor gene in hundreds of breast cancer 
patients and describe the genetic variations.  Researchers plan to genotype representative 
tagSNPs in each of the women.   
In terms of scope, the ER-β gene is 50,000bp in length.  A typical sequencing 
reaction is 250bp long, creating a total of 200 amplicons.  There are 96 samples 
sequenced, which generates almost 20,000 reactions.  For each reaction, we align the 
amplicon along the gene and search for SNPs.  Since SNP density in the human genome 
is approximately one per 200bp, we expect roughly 250 SNPs for the ER-β gene.  Finally 
we add these 250 SNPs for each of the 96 samples, creating almost 25,000 genotype 
entries in our system. 
 
  
7 
 
Project Goals and Objectives 
A computer software information management system was designed to manage 
genetic data in a clinical setting.  The software includes a data warehouse that functions 
as a central repository and staging platform to collect raw data which is then locally 
curated before being exported to public databases for storage or other external 
destinations such as bioinformatic web applications for further analysis.  The project 
goals are to implement a web-based relational database application for storage and 
retrieval of genotypic, phenotypic and resequencing data by furnishing a system that 
delivers the following functionalities: 
 Acquisition, Organization, Storage: 
1. Collect, store and annotate genotype (polymorphism) data  
2. Assemble, deposit and annotate resequencing data 
3. Acquire, organize and warehouse phenotype data 
Retrieval and Analysis: 
4. Automate submission of data to PharmGKB 
5. Format and export data to other bioinformatic applications   
6. Facilitate statistical analysis of data to elucidate genotype/phenotype 
associations. 
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Chapter Two: Background 
Currently Available Public Databases 
Genome-wide association studies that combine whole genome information with 
phenotype data to increase our understanding of human health and disease are being 
carried out at an unprecedented rate.  Yet the number of genotype/phenotype databases 
dedicated to identifying genetic factors that influence disease are relatively few.  
However, several such repositories have already been established; PharmGKB (Klein et 
al, 2001), PhenomicDB (Kahraman et al, 2005) and dbGaP (Mailman et al, 2007) are 
three currently available public genotype/phenotype databases dedicated to advancing 
research in genetic associations.  
The database of Genotype and Phenotype (dbGaP) was developed and is operated 
by the National Library of Medicine’s National Center for Biotechnology Information 
(NCBI).  The database collects research data from studies that investigate the relationship 
between genotype and phenotype, such as genome-wide association studies (GWAS).  
The database offers two levels of public access: open and controlled.  Open access grants 
the ability to retrieve summaries or studies, study documents and other related 
information.  Controlled access can be requested and includes access to individual level 
genotypes.  The database also includes an analysis of statistical association between 
genes and phenotypes.   
PhenomicDB is a multi-species genotype/phenotype database that is hosted by a 
German bioinformatics company, Metalife.  It merges data from primary databases (e.g., 
FlyBase, WormBase, NCBI, OMIM, etc.) and includes data on numerous organisms such 
as human, mouse, fruit fly and C. elegans. The database also includes orthologues to 
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allow comparison of phenotypes across many species simultaneously.  RNA interference 
(RNAi) screen data, phenotype ontology terms and assay information is also incorporated 
into PhenomicDB. 
PharmGKB is a knowledge base managed by Stanford University that warehouses 
information on drugs, diseases, phenotypes, genes, pharmacokinetics and 
pharmacodynamics.  It also integrates variant data from a number of public repositories 
including dbSNP, HapMap and jSNP.  It is the central databank for the PGRN and also 
accepts data submissions from the public.  Data about the relationships between drugs, 
genes and diseases are collected and curated with the intent to catalyze pharmacogenomic 
research. 
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Chapter Three: Methodology 
COBRA-DB is an integrated online database system that manages three major 
datasets: genotype data, phenotype data and sequencing data.  We developed a relational 
method to integrate genotype, phenotype and sequencing information.  Figure 1 shows 
the integration of the genomic data.    
 
Figure 1 COBRA-DB integrates multiple datasets 
COBRA Participants 
The Consortium on Breast Cancer Pharmacogenomics (COBRA) is a member of 
the National Institutes of Health Pharmacogenomics Research Network (PGRN).  The 
mission of the PGRN is to advance understanding of the genetic basis for variable drug 
responses.  COBRA aims to correlate genetic variation with drug response phenotypes.  
The COBRA Research Network consists of the following academic institutions: Indiana 
University, University of Michigan, Johns Hopkins University, Baylor College of 
genotypic 
data
sequencing 
data
phenotypic 
data
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Medicine and Mayo Clinic.  Members of the PGRN, including COBRA, submit data to 
the Pharmacogenomics and Pharmacogenetics Knowledgebase (PharmGKB).   
 
Figure 2 Flow of Information ending with PharmGKB submissions 
 
Data Generation, Format and Entry 
The following section explains the original sources of the derived data and 
how the data are input into the database.  When genotyping test results are available, 
they are manually transferred from the laboratory instruments by a research 
technician into a standard input file that can be automatically processed.  At this point  
in the workflow, results are verified by a laboratory supervisor acting as a data curator 
to ensure quality control.   
Genotype data are generated in the GCRC Pharmacogenetics Core Laboratory 
located in the Division of Clinical Pharmacology.  The Core Lab outsources DNA 
(re)sequencing to an external genomic service solutions company, Polymorphic DNA 
Baylor College of Medicine
University of Michigan
John Hopkins University
Mayo Clinic
Randomized Clinical Trial
INDIANA UNIVERSITY
Coordinating Core:
Analytical Core
Pharmacogenetics Core
Biostatistics Core
Bioinformatics Core
PG of Endocrine Treatment
PharmGKB
Submissions
12 
 
Technologies (www.polymorphicdna.com).   Phenotypic information is generated 
through patient surveys and clinical data.   
Database Design 
The data are stored in a relational MySQL® database running on a Linux 
server hosted at Dr. Sean Mooney’s laboratory in the Center for Computational 
Biology and Bioinformatics (CCBB) at Indiana University.  MySQL is a popular, 
industry standard open source database that provides stable performance.  MySQL is 
installed on a Linux platform with the installed version being mysql Ver 12.22 Distrib 
4.0.21, for pc-linux (i686).  The database schema for this project has been revised 
numerous times to accommodate a growing list of user requirements.   
A sample-centric approach was implemented in order to optimize the 
workflow.  The main tables hold results for each unique sample.  The tables can be 
grouped into categories with a few exceptions.  There is a cluster of tables that 
represent metadata, which includes details about the clinical trials and additional 
information about each patient and the associated biological samples.  Another group 
of tables that store data about the different assays (Restriction fragment length 
polymorphism (RFLP), Luminex®, SYBR® GreenER™, and TaqMan®) that are 
performed on the patient samples.  The assay tables also hold metadata about the 
assays such as protocol descriptions.  Another group of tables holds meta information 
about the genetic variants which the assays target.  Variant data include nucleotide, 
locus and amino acid sequence information.  Sequence data are stored in another set 
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of tables.  Other administrative information about users and sessions are also stored.  
Currently, the database is comprised of 57 non-redundant tables (Figure 3).    
  
Figure 3 List of tables in database SERM 
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Figure 4 shows the entity-relationship diagram for the database. 
 
Figure 4 Entity Relationship (ER) diagram  
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The ER diagram conceptually represents the structure of the data in a relational database.  
Each entity in the model corresponds to a discrete object (e.g., gene, patient).  
Connections between the entities represent relationships and cardinality.  For example, 
there is relationship between patient and sample.  It is possible for a patient to have one 
or many associated sample (e.g., from multiple time points).  Similarly, a gene can have 
multiple associated variants. 
Web Interface 
The SERM database can be accessed via a website and users can query the 
data via a series of user-friendly web forms.  We have streamlined the web-based 
query forms to be as simple as possible by allowing users to customize their queries.   
Querying the Data 
 
The majority of users will perform simple queries on the data, but the ability to 
generate more complex searches is available.  By leaving query options open, users 
can browse the data and sort entries by category.   Most queries simultaneously 
examine all the tables in the database and matched records are collected and a view 
page is dynamically generated and presented.  Data can also be filtered and sorted by 
any attribute such as “Gene Name” shown in Table 3 below. 
Table 2 Query results for "Gene" 
 
 Gene Name  mRNA Accession  PharmGKB Accession ID    
 CYP2C8 NM_000770 PA125 History Edit Delete 
 CYP2C9 NM_000767 PA123 History Edit Delete 
 CYP2D6 NM_000106 PA128 History Edit Delete 
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Data submission to PharmGKB 
COBRA data are submitted to the research network’s data hub, PharmGKB, 
using XML specification.  The data are encoded into structured documents that are 
machine-processable and then transported to PharmGKB.  A validation process 
ensures that the documents are both well-formed and valid in terms of semantics.  A 
sample XML export file shown in Figure 5 illustrates some of the various XML tags.   
 
Figure 5 Sample XML Export File 
System Security 
COBRA data contain patient health information that is protected by the HIPAA 
privacy rules.  As such, we implemented a HIPAA compliant system.  The website was 
properly secured using SSL, a technology that uses digital certificates to authenticate 
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users.  We use a standard PHP/MySQL implementation using session variables to save 
authentication information.  This session expires when the browser is closed.  All 
sessions are transmitted over the SSL connection, and passwords are stored in the 
MySQL database using a mix of one-way hashing algorithms such as MD5 and SHA1. 
These sessions are checked whenever an action is to be taken on the website. 
All COBRA data are kept on RAID 5 volumes ensuring that a failed hard drive 
will not cause data loss.  The web server data are backed up, and the MySQL database is 
replicated to a separate machine.  From there, our data are uploaded to the HPSS tape 
backup system hosted by Indiana University, and then are replicated to Bloomington.  All 
of these backups occur nightly, and are incremental.  Full backups occur on a weekly 
basis. 
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Bioinformatic Workflows 
The following sections describe the workflow in detail.  The methodological 
approach consists of the following steps: 
 
Figure 6 Data flow for submissions 
 
Figure 6 shows information flow for this project.  Genotype, phenotype and 
sequence data are uploaded to the internal data management system and staged for 
export to other entities such as statisticians and other databases including PharmGKB.   
Workflow for Genotype 
 
A laboratory technician performs one of several possible genotyping assays.  The 
genotype results are obtained from the laboratory equipment.  A technician or other data 
entry person enters the output into a spreadsheet format (Figure 7).  The spreadsheet 
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includes the primary keys for sample ID and variant IDs as well as the type of variant and 
the specific nucleotides for each allele. 
 
Figure 7 Excel input file for genotype submission  
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Although this approach takes considerably more time, data can also be uploaded one 
record at a time.  This method might prove useful if a technician needs to update a single 
record as opposed to a bulk entry.  Figure 8 shows the web form to add a single genotype 
record.  In cases where the lab needs to repeat an experiment on a particular sample, this 
approach is more convenient.  
 
 
Figure 8 Web form for genotype import 
  
21 
 
Figure 9 illustrates the complete workflow for genotype data.  After data is uploaded to 
the database server and imported into the database it is available for retrieval and 
analysis.   
 
Figure 9 Information flow for genotypic data 
 
Workflow for Phenotype 
 
Detailed and accurate phenotype collection is a major challenge and often a limiting 
factor to genetic association studies.  The problem is further compounded when data are 
scattered geographically.  Targeted recruitment and online surveys are the primary means 
by which data are collected for storage in the database.   
Lab tech 
performs 
genotyping 
assay
Obtain 
genotyping 
results from 
lab 
equipment
Tech enters 
output into 
spreadsheet 
format
User 
uploads 
*.xls(x) file 
to server via 
website
Data is 
imported 
into 
database
Retrieval 
and Analysis
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Figure 10 shows the workflow for phenotype data. 
 
Figure 10 Information flow for phenotypic data 
 
Workflow for Sequencing 
Patient samples are sent to Polymorphic DNA Inc. for resequencing.  Completed 
resequencing data are returned in spreadsheet format.  Perl code was developed to 
process the Excel files.  Individual scripts were written to index variants and track their 
positions in the relative sequence.  Sequence fragments were concatenated in order to 
generate FASTA formatted files.  The BLAT alignment tool (Kent 2002) was used to 
determine the position of the amplicons relative to a reference sequence (e.g., estrogen 
reference sequence).  Finally, we queried SNP databases using the derived variant 
position to look for known SNPs.  Sequencing and variant data are then stored in 
COBRA-DB.  Figure 11 shows the workflow for sequencing data. 
Patients 
complete 
written 
questionairre 
Patient survey 
answers are 
transferred to 
database using 
web form data 
entry
Phenotype 
data is stored 
in database
Data is 
exported to 
PharmGKB via 
XML
Data is publicly 
available for 
analysis
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1. Patient samples sent out for resequencing 
 
2. Resequencing done by Polymorphic DNA Inc. 
 
3. Results returned in zipped Excel files 
 
4. User uploads zip file to server via website 
 
5. Perl scripts parse and store data in DB 
 
6. FASTA files are generated from scripts 
 
7. BLAT alignment used to obtain amplicon 
 
8. Archive and update variant data in database 
 
9. Linkage disequilibrium and haplotype analysis/Submit to PharmGKB 
 
10. Facilitate association studies 
 
Figure 11 Scientific workflow for resequencing 
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Table 4 shows the main input and output files that are generated by UNIX-based scripts 
and then used in the sequencing workflow.  Parse_polydna.blat parses the Excel files 
from Polymorphic DNA and invokes the BLAT alignment tool to find sequence matches.  
The script also produces two output files, *.geno and *.mark, that include comma-
delimited genotype matrices and quality scores from the base-calling program Phred.  
Pdna_mark2rsid queries the NCBI dbSNP database for known variant identification 
numbers (i.e., rsIDs) and also assigns IDs to unknown or novel SNPs.  
Pdna_rsid2haplo_sort and Pdna_ordergeno generate the .mark.rsid and .geno files, 
respectively, that are used as input for the Haploview, a program designed to simplify and 
expedite haplotype analysis (Barrett et al, 2005). 
Table 3 UNIX-based Perl Scripts 
 
script input file output file 
Parse_polydna.blat.pl .xls .geno and .mark 
Pdna_mark2rsid .mark .mark.rsid 
Pdna_rsid2haplo_sort .mark.rsid .mark.rsid.haplo 
Pdna_ordergeno .mark.rsid and .geno .geno.o 
 
Figure 12 shows the collection of output files generated by the Perl scripts and provides a 
more detailed explanation of the contents of each file.  Table 5 shows an example of 
actual file contents. 
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Figure 12 Perl output files and description of contents 
 
 
  
• comma-delimited genotype matrix
• rows=samples, columns=markers
• order is determined by input file
*.geno
• comma-delimited genotype matrix
• includes phred read scores and IUPAC variant codes
• rows=samples, columns=markers
*.phred
• comma-delimited marker description file
• marker-id, file-pos, db-pos
• marker order corresponds to .geno and phred files (above)
*.mark
• Fasta formatted sequence file
• header: > file=x, size=y, varpos=z
*.fa
• details all information related to .xls file names, db names, alignment results, etc.
*.key1, *.key2
• written during  script execution
• details files parsed, alignment, variants written/not written, etc.
*.log
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Table 4 Screenshots of sequence output files 
 
.geno 
sample,SNP009_Discovery.xls_105,SNP009_Discovery.xls_178,SNP009_Discovery.xls_191,SNP009_
Discovery.xls_205,SNP009_Discovery.xls_242,SNP010_Discovery.xls_68,SNP010_Discovery.xls_1
95,SNP014_Discovery.xls_88,SNP014_Discovery.xls_252,SNP015_Discovery.xls_268,SNP017_Disco
very.xls_117,SNP017_Discovery.xls_126,SNP017_Discovery.xls_144,SNP019_Discovery.xls_138,S
NP019_Discovery.xls_148,SNP019_Discovery.xls_164,SNP023_Discovery.xls_52,SNP023_Discovery
.xls_118,SNP024_Discovery.xls_98,SNP024_Discovery.xls_139,SNP024_Discovery.xls_220,SNP026
_Discovery.xls_40,SNP026_Discovery.xls_178,SNP026_Discovery.xls_259,SNP026_Discovery.xls_
266, 
AA34,G/G,G/G,G/G,G/G,A/A,T/T,T/T,C/C,G/G,A/A,C/C,G/G,T/T,G/G,G/G,C/C,A/A,A/A,A/A,G/G,C/C 
AA41,G/G,G/G,G/G,G/G,A/G,T/T,T/T,C/T,G/G,A/A,C/C,G/G,T/T,G/G,A/A,G/G,A/A,A/A,A/A,A/G,C/C 
AA09,G/G,G/G,G/G,G/G,A/A,T/T,T/T,C/T,G/G,A/A,C/C,G/G,T/T,G/G,A/G,C/G,A/A,A/A,A/A,G/G,C/C 
...etc. 
.phred 
sample,SNP009_Discovery.xls_105,SNP009_Discovery.xls_178,SNP009_Discovery.xls_191,SNP009_
Discovery.xls_205,SNP009_Discovery.xls_242,SNP010_Discovery.xls_68,SNP010_Discovery.xls_1
95,SNP014_Discovery.xls_88,SNP014_Discovery.xls_252,SNP015_Discovery.xls_268,SNP017_Disco
very.xls_117,SNP017_Discovery.xls_126,SNP017_Discovery.xls_144,SNP019_Discovery.xls_138,S
NP019_Discovery.xls_148,SNP019_Discovery.xls_164,SNP023_Discovery.xls_52,SNP023_Discovery
.xls_118,SNP024_Discovery.xls_98,SNP024_Discovery.xls_139,SNP024_Discovery.xls_220,SNP026
_Discovery.xls_40,SNP026_Discovery.xls_178,SNP026_Discovery.xls_259,SNP026_Discovery.xls_
266, 
AA34,G(58),G(69),G(63),G(55),A(34),T(55),T(65),C(54),G(46),A,C(53),G(54),T(64),G(66),G(61
),C(67),A(56),A(47),A(64),G(64),C(66),G(61),T(50),T(63),A(63),AA41,G(57),G(66),G(63),G(65
),R(20),T(64),T(63),Y(29),G(56),A,C(66),G(33),T(62),G(66),A(65),G(44),A(66),A(59),A(67),R
(32),C(62),G(59),T(53),T(55),A(44)...etc. 
.mark 
variant,file-pos,NC_000014.7 
SNP009_Discovery.xls_105,105,63769935 
SNP009_Discovery.xls_178,178,63769862 
SNP009_Discovery.xls_191,191,63769849 
SNP009_Discovery.xls_205,205,63769835 
SNP009_Discovery.xls_242,242,63769798 
SNP014_Discovery.xls_88,88,63770492...etc. 
.fa 
>file=SNP009_Discovery.xls nbases=247 varpos=105,178,191,205,242 
TTGTCCTATGTGTCAGGCCATTGTAGGTGTGTGGTGGGACACAGAGGCTGACAAGACATCGTCCTTGCCCTTGAGCCTAAATTATCAGG
GGGAGCTGGATGCACGAGCCATGGATAAATGGGCTGGGGGAAGAGTGGGTTTAGGGGTGGGGTAGACTGGCTCTGAGCAAAGAGAGCCG
GGGAAGGCTTCGGGGTTCCTGTGGCTGCCTCGGAGGAGGGAATCTCAGCACCTTTTTGTCCCCATAGTA...etc. 
.key1 
file      :SNP009_Discovery.xls 
blastdb   :NC_000014.7 
db_start  :63770039 
db_end    :63769793 
ref-seq 
:TTGTCCTATGTGTCAGGCCATTGTAGGTGTGTGGTGGGACACAGAGGCTGACAAGACATCGTCCTTGCCCTTGAGCCTAAATTATCAG
GGGGAGCTGGATGCACGAGCCATGGATAAATGGGCTGGGGGAAGAGTGGGTTTAGGGGTGGGGTAGACTGGCTCTGAGCAAAGAGAGCC
GGGGAAGGCTTCGGGGTTCCTGTGGCTGCCTCGGAGGAGGGAATCTCAGCACCTTTTTGTCCCCATAGTA 
n-bases   :247 
ins-pos   : 
del-pos   : 
var-pos   :105,178,191,205,242 
db-var-pos:63769935,63769862,63769849,63769835,63769798...etc. 
.log 
PARSING FILES:  
=========================================  
FILE      : serm/sequence_data/testing/0125C_P1_20051020/SNP009_Discovery.xls  
SHEETCOUNT: 1  
SHEET     : 0125CSNP009 001-247  
REFSEQ    : 
TTGTCCTATGTGTCAGGCCATTGTAGGTGTGTGGTGGGACACAGAGGCTGACAAGACATCGTCCTTGCCCTTGAGCCTAAATTATCAGG
GGGAGCTG...etc. 
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Bulk download 
In order to prevent users from bogging down the system with repeated queries which 
may lead to a potential decrease in website performance, data are available for bulk 
download as Excel, XML, flat files or as relational tables.   
 
PHP Code 
The server-side scripting language PHP was used to establish connectivity 
between the database and the web interface.  Embedded within HTML, PHP was used 
to create dynamic web pages for the front end of the system.  Programs for import and 
export have been written in PHP, XML and Perl. 
 
PharmGKB Submissions 
As part of the PGRN network COBRA submits data to the publicly accessible 
knowledge database, Pharmacogenomics and Pharmacogenetics Knowledge base 
(PharmGKB) using XML specification.  The data are encoded into structured 
documents that are machine-processable and relatively legible by humans and then 
transported to PharmGKB.  A validation process ensures that the documents are both 
well-formed and valid in terms of semantics.  Figure 13 shows a XML-formatted 
export file and includes numerous XML tags from the PharmGKB schema on which 
the code was based. 
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<?xml version="1.0" encoding="UTF-8" ?> 
  <pharmgkb xmlns="http://www.pharmgkb.org/schema/" 
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
    xsi:schemaLocation="http://www.pharmgkb.org/schema/ " 
    http://www.pharmgkb.org/schema/root.xsd"> 
    <gene localId="GENE1"> 
      <altName>estrogen receptor 1</altname> 
      <altSymbol>ESR1</altSymbol> 
      <xref resource="PUbMed">2099</xref> 
    </gene> 
    <subject localId="PA126722129"> 
      <sex>female</sex> 
      <race> 
        <nihCategory>white</nihCategory> 
      </race> 
    <subject> 
    <sample localId="SAMPLE1"> 
      <subjectXref resource="local">PA126722129</subjectXref> 
      <timestamp>10/13/2004</timestamp> 
    </sample> 
    <sampleSet localId="SAMPLESET1"> 
      <sampleXref resource="local">SAMPLE1</sampleXref> 
    </sampleSet> 
    <referenceSequence> 
      <geneXref resource=”local”>GENE1</geneXref> 
      <dnaSequence>aaacccgggttt</dnaSequence> 
      <dnaSequenceSource>genomic</dnaSequenceSource> 
      <experiment localId=”EXPERIMENT1”> 
        <pcrAssay localId=”PCRASSAY1”> 
          <amplicon> 
            <startPosition>532</startPosition> 
            <stopPosition>1025</stopPosition> 
          </amplicon> 
          <method> 
            <name>ESRI_IVSI-401</name> 
            <type>Other</type> 
            <templateType>Unknown</templateType> 
            <multiPcrAmplificationTested>False</multiPcrAmplificationTested> 
            <multiClonesTested>False</multiClonesTested> 
            <description>ESRI_IVSI-401</description> 
            <parameters> 
              PCR Protocol: Add .5 ul of the primer working stock to each PCR tube…  
            </parameters> 
          </method> 
        </pcrAssay> 
        <sampleSetXref resource="local">SAMPLESET1</sampleSetXref> 
        <genotypesInSample localId="GIS1"> 
          <genotypingResult localId="RESULT1"> 
            <assayXref resource=”local”>”PCRASSAY1</assayXref? 
            <variant localId="VARIANT1"> 
              <position>12</position> 
              <allele>T</allele> 
            </variant> 
            <variant localId="VARIANT2"> 
              <position>13</position> 
              <allele>C</allele> 
            </variant> 
          </genotypingResult> 
        <genotypesInSample> 
      </expirement> 
    </referenceSequence> 
  </pharmgkb> 
</xml> 
 
Figure 13 Sample XML Export File 
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Data Analysis 
Statisticians use the data warehouse as an internal tool to conduct phenotype 
genotype association studies.  The data can be used to help correlate drug response 
phenotypes with genetic variation.  More specifically, the data can be used to perform a 
variety of statistical analysis including genetic linkage analysis (e.g., linkage 
disequilibrium analysis, SNP haplotype reconstruction) and other statistical tests.  
Similarly, the data can be used as input for other in silico testing related to human disease 
research.  
System Administration 
The database includes a web-based system administration panel that allows 
administrators to manage system tasks such as the creation, modification or deletion of 
database entities such as laboratories, samples, assays and users.  Likewise, 
administrators and group of super users can manage the dataset of results.  User 
authentication roles have been created to establish tiered access.  Administration of the 
database itself is accomplished over the web via the MySQL database administration 
tool, phpMyAdmin.  Database administrators can effectively create and alter tables, 
manage privileges, add/edit/delete data and perform other standard admin tasks.   
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Chapter Four: Results and Discussion 
The web interface was designed in order to allow users to perform queries in a 
straightforward manner.  To that end, we have created simple web forms for querying the 
data.  Figure 14 shows the form used to query variant data.  Users can customize the 
search by populating the fields in the form with search criteria.  Searches can be further 
narrowed by entering additional terms.  In this example, the figure shows a custom search 
for a SNP with a given rsID number (i.e, rs1065852). 
 
Figure 14 Query variant form 
   
Figure 15 shows the returned results from the above query and includes the Variant Type 
(SNP), variant Id (auto-incremented primary key), Variant Name (arbitrary), Gene Name 
(NCBI Official Symbol), Aminoacid _1 (wildtype amino acid), Aminoacid_2 (amino acid 
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change due to variant), Allele_1 (wildtype allele), Allele_2 (mutant allele) and RsID 
(dbSNP identification number).  The results also show administrative functions such as 
delete and edit.  These options are only available when the user is logged in as an 
administrator. 
 
Figure 15 Search results for variant rs1065852 
 
We are able to efficiently submit data to PharmGKB, which fulfills a major 
business need, which is satisfying metrics for grant renewals.  Table 5 shows a summary 
of COBRA-DB records to date and illustrates the volume of data which this system 
supports. 
Database Contents 
Table 5 Summary of database records 
 
Variants 33 
Assays 31 
Patients/Samples 305 
Genotypes 890 
Genes 22 
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Data can also be filtered and sorted by any attribute such as “Local ID” shown 
in Table 6 below.  This table shows example results for querying the Sample table. 
Table 6 Query results for "Sample" 
 
 Local ID  Sample Name  Time Point    
 IU047 Blood 721 0 months History Edit Delete 
 IU048 Blood 722 0 months History Edit Delete 
 IU049 Blood 723 0 months History Edit Delete 
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Sequence Data Files and Haploview 
 Users can query sequence data via the web interface and download raw data files 
for input into the software program Haploview developed by Dr. Mark Daly’s lab at the 
Harvard Broad Institute (www.broad.mit.edu/mpg/haploview/) (Barrett et al, 2005).  
Users can also automatically launch Haploview (ver. 4.0) directly from the website.  
Haploview is a web-based haplotype analysis tool that performs linkage disequilibrium 
(LD) analysis and haplotype block analysis among other tests. 
 
Figure 16 Haploview LD Plot 
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Figure 16 shows a typical LD plot generated in Haploview.  The plot is used to analyze 
and visualize patterns of linkage disequilibrium in genetic data.  The top of the figure 
includes a map that shows the locations of variants followed by labels for those same 
variants.  Variants are labeled with the prefix unk- or rs- depending on whether they are 
novel or previously unknown or already exist in NCBI’s dbSNP database, respectively. 
Haploview accepts input data in five formats.  Figure 17 is a sample file 
containing linkage data in standard linkage format.  The last eight columns are paired 
(one column for each allele) and coded as 1-4 where 1=A, 2=C, 3=G and T=4 (0 
indicates missing data). 
Name ID father mother sex affection marker genotypes 
 
712773 AA34 0 0 2 2 2 2 2 2 2 2 1 1 4 4 3 3 2 2 3 3 1 3 4 4 4 4 
712773 AA41 0 0 2 2 2 2 2 2 2 2 1 1 4 4 3 3 2 2 3 3 1 1 4 4 3 4 
712773 AA09 0 0 2 2 2 2 2 2 2 2 1 1 4 4 3 3 2 2 3 3 1 1 4 4 4 4 
712773 CA22 0 0 2 2 2 2 2 2 2 2 1 1 4 4 3 3 2 2 3 3 1 1 4 4 4 4 
712773 AA40 0 0 2 2 2 2 2 2 2 2 1 1 4 4 3 3 2 2 3 3 1 3 4 4 4 4 
 
 
Figure 17 Linkage data flat file 
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The flat file pdna.mark.rsid.haplo includes a list of known (rs) and unknown 
(unk) SNPs in the first column, followed by each of their chromosomal positions per the 
respective NCBI genomic contig (Figure 18).  
 
 
unk3531  63771894 
rs1256063 63771970 
unk3532  63772099 
unk3533  63773569 
unk3534  63773596 
unk3535  63773636 
unk3536  63775566 
rs34515626 63775623 
unk3537  63775854 
unk3538  63776968 
rs12437103 63776987 
 
 
Figure 18 Variant ID data file 
PharmGKB Submissions 
 
 The following tables (Tables 8 and 9) illustrate COBRA data submissions to 
PharmGKB as of May 2008. 
Table 7 PharmGKB Genotype Submissions by COBRA 
 
Genotype Submissions Number of Variants 
ABCB1 79 
CYP19A1 98 
CYP2A7P1 26 
CYP2B6 26 
CYP2C19 27 
CYP2C9 22 
CYP2D6 23 
CYP3A 304 
CYP3A5 64 
ESR1 4 
ESR2 51 
HTR2A 4 
NOS3 120 
SULT1A1 45 
SULT1A2 53 
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Table 8 PharmGKB Phenotype Submissions by COBRA 
 
Phenotype Submissions Number of Patients (n) 
Patient responses to tamoxifen 30 
Lipid measurements in tamoxifen study 61 
Patient responses to tamoxifen (dataset 2) 61 
Lipid measurements in tamoxifen study (dataset 2) 104 
Thyroid binding globulin in tamoxifen patients 60 
Hot flashes in tamoxifen patients 169 
Pharmacokinetics of tamoxifen at 4 months 54 
 
 
 
Figure 19 COBRA ESR1 PharmGKB Submission 
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 The previous figure (Figure 19) represents one of many COBRA submissions to 
PharmGKB. 
Submitting data efficiently has been a major improvement.  As described 
previously, data submission was a major problem, traditionally a laborious task, and 
caused a bottle neck effect in the work flow, which ultimately hindered research and 
negatively impacted grant renewals. 
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Chapter Five: Conclusions 
COBRA-DB is an online information management tool for the storage, organization 
and export of pharmacogenomic data related to breast cancer and drug responses.  A 
relational model provides integration of multiple data sets while a web interface supports 
trouble-free data import and export.  Simple query forms provide users with a tool to 
perform uncomplicated searches.  Data annotation provides information to facilitate 
genotype/phenotype association studies that will help advance pharmacogenomic breast 
cancer research.   
Limitations 
In terms of quality control, it is important to note that the information system does 
not interface directly with laboratory instruments.  Unfortunately, a human operator is 
needed to transfer output from lab devices and perform an initial formatting of the data.  
At this point in the workflow, the system is vulnerable to human error and this issue 
requires attention on a quality control level.   
Haplotype data also presented a challenge.  Initially, the database was not designed 
to store haplotype data.  However, the schema was updated in an attempt to include 
haplotype results, but the database has not been completely populated due to an 
unresolved and still outstanding issue relating to nomenclature used to describe variants 
in the Cytochrome P450 system, a group of drug-metabolizing enzymes.  Once a 
consensus on nomenclature is reached, efforts to fully incorporate haplotype results will 
be resumed.         
 Similarly, the inherent fluidity present in biological data presented a related 
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challenge.  Developing a system that can be easily adapted to concepts which are highly 
susceptible to change presents a technical challenge.  As new data are collected or as data 
evolve, the database must be extended to accommodate the new information. 
Finally, providing an accurate estimate of confidence in the data was difficult.  
Statistical quality measures were lacking from the quality control process.  We aim to 
address this and the other limitations of this study in our future work. 
Future Enhancements 
In accordance with budget and time constraints, we propose to upgrade the system 
by incorporating the following improvements.   
Multiplex Assay Data 
We intend to extend the current database model to support new data generated by 
multiplex SNP detection assays.  Currently, the schema is configured to handle one 
unique variation per assay and would need to be expanded to include storage for 
additional results. 
Web-based Reporting 
User requirements have indicated that the addition of web-based reporting tools 
would be beneficial.  Web-based reports can be used to generate data summaries to help 
track data and deliver a complete data picture.  Reports can also generate effective charts 
and graphs to help manage project progress.  
Haplotype Data 
Future version of the database will include updates to feature haplotype 
information.  Presently, variation data can be visualized as individual genotypes.  
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However, an aggregated view of these variations would be helpful for linkage 
disequilibrium (LD) and haplotype analysis. 
Software distribution 
Finally, we have started the process to bundle the software for distribution to other 
parties.  Other members within the PGRN work with similar datasets and struggle with 
similar data management issues and have expressed an interest in our system.  We plan to 
share the software with COBRA collaborators and offer the system to PharmGKB for 
distribution on their website to a broader audience.   
Summary 
We have created a web-based information system to manage genotype, phenotype 
and sequence data for COBRA.  The integration of this data is an essential step for 
performing holistic pharmacogenomic analysis.  Assembly of data is a first step to 
understanding the associations between genetic variation and phenotype response and 
expanding our knowledge of drug response in individuals.  The relational database serves 
as a staging ground to organize and annotate the data before it is transported to public 
repositories such as PharmGKB or other bioinformatic applications for further such 
analysis.  By combining these datasets via a relational database, investigators are able to 
access the information and perform research in a straightforward and simple manner.  
The system also ensures data integrity by adhering to best practices in security.  As the 
amount of information from genomic studies rapidly increases, COBRA-DB can be 
extended to incorporate new data. 
  
41 
 
References 
Abdullah Kahraman, Andrey Avramov, Lyubomir Nashev, Dimitar Popov, Rainer 
Ternes, Hans-Dieter Pohlenz, and Bertram Weiss.  PhenomicDB: a multi-species 
genotype/phenotype database for comparative phenomics. 
Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and 
haplotype maps.  Bioinformatics.  2005 Jan 15. 
Frenkel, KA.  The Human Genome Project and Informatics.  Communications of the 
ACM.  1991 Nov; 34(11):41-51. 
Hernandez-Boussard T, Whirl-Carrillo M, Hebert JM, Gong L, Owen R, Gong M, Gor 
W, Liu F, Truong C, Whaley R, Woon M, Zhou T, Altman RB, Klein TE.  The 
pharmacogenetics and pharmacogenomics knowledge base: accentuating the 
knowledge.  Nucleic Acids Res. 2008 Jan;36(Database issue):D913-8. 
Giacomini KM, Brett CM, Altman RB, Benowitz NL, Dolan ME, Flockhart DA, Johnson 
JA, Hayes DF, Klein T, Krauss RM, Kroetz DL, McLeod HL, Nguyen AT, Ratain 
MJ, Relling MV, Reus V, Roden DM, Schaefer CA, Shuldiner AR, Skaar T, 
Tantisira K, Tyndale RF, Wang L, Weinshilboum RM, Weiss ST, Zineh I; 
Pharmacogenetics Research Network.  The pharmacogenetics research network: 
from SNP discovery to clinical drug response.  Clin Pharmacol Ther. 2007 
Mar;81(3):328-45. Review.  
Goetz MP, Rae JM, Suman VJ, Safgren SL, Ames MM, Visscher DW, Reynolds C, 
Couch FJ, Lingle WL, Flockhart DA, Desta Z, Perez EA, Ingle JN.  
Pharmacogenetics of tamoxifen biotransformation is associated with clinical 
outcomes of efficacy and hot flashes.  J Clin Oncol. 2005 Dec 20;23(36):9312-8. 
42 
 
Goh CS, Gianoulis TA, Liu Y, Li J, Paccanaro A, Lussier YA, Gerstein M.  Integration 
of curated databases to identify genotype-phenotype associations.  BMC 
Genomics. 2006 Oct 12;7:257. 
Groth P, Pavlova N, Kalev I, Tonov S, Georgiev G, Pohlenz HD, Weiss B.  
PhenomicDB: a new cross-species genotype/phenotype resource.  Nucleic Acids 
Res. 2007 Jan;35(Database issue):D696-9. 
Hernandez-Boussard T, Woon M, Klein TE, Altman RB.  Integrating large-scale 
genotype and phenotype data.  OMICS.  2006 Winter;10(4):545-54. 
Hewwett M, Oliver DE, Rubin DL, Easton KL, Stuart JM, Altman RB, Klein TE.  
PharmGKB: the Pharmacogenetics Knowledge Base.  Nucleic Acids Res. 2002 
Jan 1;30(1):163-5. 
Kahraman A, Avramov A, Nashev LG, Popov D, Ternes R, Pohlenz HD, Weiss B.  
PhenomicDB: a multi-species genotype/phenotype database for comparative 
phenomics.  Bioinformatics. 2005 Feb 1;21(3):418-20. 
Kent, JW.  BLAT – The BLAST-Like Alignment Tool.  Genome Research. 2002 Apr 
12(4):656-664. 
Mailman MD, Feolo M, Jin Y, Kimura M, Tryka K, Bagoutdinov R, Hao L, Kiang A, 
Paschall J, Phan L, Popova N, Pretel S, Ziyabari L, Lee M, Shao Y, Wang ZY, 
Sirotkin K, Ward M, Kholodov M, Zbicz K, Beck J, Kimelman M, Shevelev S, 
Preuss D, Yaschenko E, Graeff A, Ostell J, Sherry ST.  The NCBI dbGaP 
database of genotypes and phenotypes.  Nat Genet. 2007 Oct;39(10):1181-6. 
Ntukidem NI, Nguyen AT, Stearns V, Rehman M, Schott A, Skaar T, Jin Y, Blanche P, 
Li L, Lemler S, Hayden J, Krauss RM, Desta Z, Flockhart DA, Hayes DF; 
43 
 
Consortium on Breast Cancer Pharmacogenomics.  Estrogen receptor genotypes, 
menopausal status, and the lipid effects of tamoxifen.  Clin Pharmacol Ther. 2008 
May;83(5):702-10. 
Owen RP, Altman RB, Klein TE.  PharmGKB and the International Warfarin 
Pharmacogenetics Consortium: the changing role for pharmacogenomic databases 
and single-drug pharmacogenetics.  Hum Mutat. 2008 Apr;29(4):456-60. 
Price TD, Qvarnström A, Irwin DE.  The role of phenotypic plasticity in driving genetic 
evolution.  Proc Biol Sci. 2003 Jul 22;270(1523):1433-40.  
T.E. Klein, J.T. Chang, M.K. Cho, K.L. Easton, R. Fergerson, M. Hewett, Z. Lin, Y. Liu, 
S. Liu, D.E. Oliver, D.L. Rubin, F. Shafa, J.M. Stuart and R.B. Altman, 
"Integrating Genotype and Phenotype Information: An Overview of the 
PharmGKB Project", The Pharmacogenomics Journal (2001) 1, 167-170. 
Whirl-Carrillo M, Woon M, Thorn CF, Klein TE, Altman RB.  An XML-based 
interchange format for genotype-phenotype data.  Hum Mutat. 2008 
Feb;29(2):212-9.  
 
Websites 
 
1. www.broad.mit.edu/mpg/haploview 
2. www.ncbi.nlm.nih.gov 
3. www.pharmgkb.org 
4. www.phenomicdb.de 
5. www.polymorphicdna.com 
 
44 
 
  
45 
 
Appendices 
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Appendix A: Representative Code  
The following PHP code accesses and displays contents of database tables. 
 
 
/*  Filename: view_gene.php 
    Last Update: Oct. 26, 2007 
    Description: Displays gene table 
*/ 
 
<?php 
        include("include/function.inc.php"); 
        session_start(); 
        check_session(); 
 
        db_connect(); 
        if(isset($_GET['gene_id'])) 
        { 
                $gene_id = $_GET['gene_id']; 
 
                $sql = "SELECT * FROM gene WHERE gene_id = '$gene_id';"; 
                $result = mysql_query($sql); 
                if(!$result || mysql_num_rows($result) < 1) 
                { 
                        error("There are no genes that exist with that gene id"); 
                        exit(-1); 
                } 
                else 
                { 
          
                        $gene_id = mysql_result($result, 0, "gene_id"); 
                        $symbol = mysql_result($result, 0, "symbol"); 
                        $mrna_acc = mysql_result($result, 0, "mrna_acc"); 
                        $pharmgkb_id = mysql_result($result,0,"pharmgkb_id"); 
 
 
                } 
        } 
        else 
        { 
                error("You must specify an gene_id"); 
                exit(-1); 
        } 
        db_close(); 
        page_start("query", "View Gene"); 
?> 
 
<table width="50%"> 
        <tr class="header"><td>View Gene</td></tr> 
        <tr><td class="field">Gene Id:</td><td><?php print("$gene_id"); ?></td></tr> 
        <tr><td class="field">Gene Symbol:</td><td><?php print($symbol); ?></td></tr> 
        <tr><td class="field">mRNA_Accession:</td><td><?php print($mrna_acc); 
?></td></tr> 
        <tr><td class="field">pharmGKB_Id:</td><td><?php print($pharmgkb_id); 
?></td></tr> 
 
</table> 
 
<?php 
        page_stop(); 
?> 
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Appendix B: PharmGKB XML Schema 
 
NOTE: This figure only includes the portions of the schema relevant to COBRA 
submissions. 
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Appendix C: Definitions of Database Terms 
The following terms are linked to web forms associated with importing data: 
 Technician(Id/Name)  User ID of laboratory research analyst 
 Date Ran   Date an assay was performed 
 Study Name   Official name of clinical trial 
 Submission Name  Arbitrary name to describe an import event 
 IRB Number   Internal Review Board approval number 
 PI Name   Real name of Principal Investigator 
 Clinical Trials Gov ID Id number from Clinical Trial (clinicaltrials.gov) 
 Date Approved  Data the study was approved 
 Grant ID   Id number for grant 
 Gene Symbol   NCBI Official Symbol 
 mRNA Accession  NCBI Accession number 
 PharmGKB ID  Accession ID for PharmGKB 
 Variant Type   Type of mutation (SNP, indel, VNTR) 
 Variant Name   Arbitrary name to describe variation 
  VNTR Sequence  Actual DNA sequence of tandem repeat 
 Amino Acid Change  3-letter code changes for amino acids 
  Interrogated Position  Locus of variation (bp) 
 Allele 1   Specifies A,C,G,T 
 Allele 2   Specifies A,C,G,T 
 RS Id    dbSNP ID number 
 Source    Source of SNP (dbSNP, HapMap, jSNP) 
 Assay Type   Type of assay (RFLP, TaqMan, Sybr, Luminex) 
 Assay Name   Arbitrary name to describe assay 
 Forward Primer Sequence DNA sequence of forward primer 
  Reverse Primer Sequence DNA sequence of reverse primer 
 Amplicon Wild Type (bp) Size of wildtype amplicon 
 Amplicon Mutation Type Size of mutation amplicon  
 Variant   Arbitrary name of variant 
 Interrogated Position  Locus of variant 
 Protocol Description  Description of assay protocol 
 Assay Type Name  Arbitrary name of assay 
 Local Id   Clinical Pharmacology Id for subject 
 Race    Race as specified by NIH 
 Gender   Male or female 
 Ethnicity   Ethnicity as specified by NIH 
 Age    Patient’s age at start of trial 
 Sample Type   Type of biological sample (blood, saliva) 
 TimePoint   Data time point for collection of samples/data 
 Patient    De-identified number 
  
49 
 
Appendix D: Curriculum Vitae 
c u r r i c u l u m   
v i t a e  
REBECCA FLETCHER 
 
 
becalyna@gmail.com 
 (317) 965-0962 
4502 Lakeridge Drive 
Indianapolis, IN, 46222 USA 
 
Education 
 
Master of Science in Bioinformatics, May 2008 
School of Informatics, Indiana University Purdue University at Indianapolis (IUPUI) 
Thesis: Genotype Information Management System 
Advisor: Sean D. Mooney, PhD 
 
Bachelor of Arts in Spanish for the Professions, May 1998 
Marquette University, USA 
 
Research Interests 
 
 Pharmacogenomics 
 Genotype/phenotype associations 
 Integrating large-scale genomic data 
 
Professional Experiences 
 
Bioinformatics Manager, Division of Clinical Pharmacology, Indiana University School 
of Medicine, Indianapolis, IN 
Aug 2003 – Present 
 
Internet Security Engineer, Symantec Corporation 
Nov 2002 – Aug 2003 
 
Web Hosting Engineer, UUNET Technologies, Inc. 
Feb 2000 – Nov 2002 
 
Research Assistant, Japan Bank for International Cooperation 
Feb 1999 – Feb 2000 
 
Translator/Interpreter, ESL educator, Center for Professional Translation and 
Interpretation (CETIP), Mexico 
May 1998 – Sep 1998 
